183 related articles for article (PubMed ID: 15794069)
41. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung.
Braciak TA; Bacon K; Xing Z; Torry DJ; Graham FL; Schall TJ; Richards CD; Croitoru K; Gauldie J
J Immunol; 1996 Dec; 157(11):5076-84. PubMed ID: 8943417
[TBL] [Abstract][Full Text] [Related]
43. [The value of regulated upon activation normal T cell expressed and secreted in the pathogenesis of varicose ulcer of lower limbs].
Chen LH; Liu DY; Xiong J; Ye CS; Yin HH; Wang SM
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(21):1460-3. PubMed ID: 19953896
[TBL] [Abstract][Full Text] [Related]
44. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
45. Cytological and tissue eosinophilia correlations in nasal polyposis.
Armengot M; Garín L; de Lamo M; Krause F; Carda C
Am J Rhinol Allergy; 2010; 24(6):413-5. PubMed ID: 21144220
[TBL] [Abstract][Full Text] [Related]
46. [Effect of rantes (regulated on activation, normal T expressed and secreted) on eosinophil adhesion to plasma coated glass using eosinophilic cell line (EoL-1)].
Kakazu T; Chihara J; Saito A; Nakajima S
Arerugi; 1995 Apr; 44(4):491-7. PubMed ID: 7541195
[TBL] [Abstract][Full Text] [Related]
47. Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis.
Coulomb-L'Hermine A; Capron F; Zou W; Piard F; Galateau F; Laurent P; Crevon MC; Galanaud P; Emilie D
Hum Pathol; 2001 Mar; 32(3):320-6. PubMed ID: 11274642
[TBL] [Abstract][Full Text] [Related]
48. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.
Lim KG; Wan HC; Bozza PT; Resnick MB; Wong DT; Cruikshank WW; Kornfeld H; Center DM; Weller PF
J Immunol; 1996 Apr; 156(7):2566-70. PubMed ID: 8786320
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of RANTES in nasal polyps from patients with cystic fibrosis.
Scapa VI; Ramakrishnan VR; Mudd PA; Kingdom TT
Int Forum Allergy Rhinol; 2011; 1(3):157-60. PubMed ID: 22287365
[TBL] [Abstract][Full Text] [Related]
50. The effect of nasal polyp epithelial cells on eosinophil activation.
Shin SH; Lee SH; Jeong HS; Kita H
Laryngoscope; 2003 Aug; 113(8):1374-7. PubMed ID: 12897562
[TBL] [Abstract][Full Text] [Related]
51. Effects of Fluticasone Furoate Nasal Spray on Parameters of Eosinophilic Inflammation in Patients With Nasal Polyposis and Perennial Allergic Rhinitis.
Špadijer Mirković C; Perić A; Vukomanović Đurđević B; Vojvodić D
Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):573-580. PubMed ID: 28587510
[TBL] [Abstract][Full Text] [Related]
52. RANTES production from mononuclear cells in response to the specific allergen in asthma patients.
Oyamada H; Kamada Y; Saito N; Tsuda A; Urayama O; Yamada H; Hirasawa H; Yamaguchi K; Ueki S; Chihara J
Allergol Int; 2006 Sep; 55(3):253-9. PubMed ID: 17075265
[TBL] [Abstract][Full Text] [Related]
53. Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic sinusitis: a histopathological and immunohistochemical study.
Berger G; Kattan A; Bernheim J; Ophir D
Laryngoscope; 2002 Apr; 112(4):738-45. PubMed ID: 12150532
[TBL] [Abstract][Full Text] [Related]
54. [Melatonin expression in nasal polyps in patients with asthmatic triad].
Evsiukova EV; Okuneva EIu; Zubzhitskaia LB; Kvetnoĭ IM
Arkh Patol; 2008; 70(3):33-5. PubMed ID: 18727430
[TBL] [Abstract][Full Text] [Related]
55. A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation.
Fraccaroli L; Alfieri J; Larocca L; Calafat M; Mor G; Leirós CP; Ramhorst R
Hum Reprod; 2009 Jan; 24(1):166-75. PubMed ID: 18824472
[TBL] [Abstract][Full Text] [Related]
56. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
57. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis.
Sena AA; Provazzi PJ; Fernandes AM; Cury PM; Rahal P; Oliani SM
Clin Exp Allergy; 2006 Oct; 36(10):1260-7. PubMed ID: 17014434
[TBL] [Abstract][Full Text] [Related]
58. Elevated plasma RANTES levels in patients with atopic dermatitis.
Yamada H; Chihara J; Matsukura M; Yasuba H; Yudate T; Tezuka T
J Clin Lab Immunol; 1996; 48(2):87-91. PubMed ID: 16296266
[TBL] [Abstract][Full Text] [Related]
59. Expression and secretion of RANTES (CCL5) in granulomatous calcified tissue before and after lipopolysaccharide treatment in vivo.
Castellani ML; Shanmugham LN; Petrarca C; Simeonidou I; Frydas S; De Colli M; Vecchiet J; Falasca K; Tetè S; Salini V; Conti P
Calcif Tissue Int; 2007 Jan; 80(1):60-7. PubMed ID: 17164972
[TBL] [Abstract][Full Text] [Related]
60. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor.
Ramanathan M; Spannhake EW; Lane AP
Laryngoscope; 2007 Oct; 117(10):1839-43. PubMed ID: 17906500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
